PMID: 16613307Apr 15, 2006Paper

Macrophage uptake of ultra-small iron oxide particles for magnetic resonance imaging in experimental acute cardiac transplant rejection

Acta Radiologica
Eva PennoHåkan Ahlström

Abstract

To discriminate between acutely rejecting and non-rejecting transplanted hearts using a blood pool contrast agent and T2* magnetic resonance imaging (MRI) in a clinical 1.5T scanner. Allogeneic and syngeneic heterotopic heart transplantations were performed in rats. One allogeneic and one syngeneic group each received either the ultra-small iron oxide particle (USPIO), at two different doses, or no contrast agent at all. MRI was performed on postoperative day 6. Immediately after the MR scanning, contrast agent was injected and a further MRI was done 24 h later. Change in T2* was calculated. No significant difference in change in T2* could be seen between rejecting and non-rejecting grafts in either of the doses, or in the control groups. There was a difference between the allogeneic group that received the higher contrast agent dose and the allogeneic group that did not receive any contrast agent at all. In our rat model, measurements of T2* after myocardial macrophage uptake of AMI-227 in a clinical 1.5T scanner were not useful for the diagnosis of acute rejection.

References

Dec 31, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A KlemmG Stein
Oct 24, 2000·The Journal of Thoracic and Cardiovascular Surgery·S KannoC Ho
Jun 26, 2001·Seminars in Dialysis·V R Peddi, M R First
Dec 1, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L ChanS Hariharan
Jun 25, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David O TaylorMarshall I Hertz

❮ Previous
Next ❯

Citations

Mar 2, 2011·Current Cardiovascular Imaging Reports·Yijen L WuChien Ho
Sep 22, 2015·Chemical Society Reviews·Hamed AramiKannan M Krishnan
Mar 3, 2017·Pflügers Archiv : European journal of physiology·Manfred NairzGuenter Weiss
Apr 1, 2009·Circulation·Thomas ChristenPeter Libby
May 24, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·E Bracho-SanchezB G Keselowsky
Sep 24, 2010·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Chih-Lung ChenChien Ho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.